Metoclopramide in pregnancy and risk of major congenital malformations and fetal death

JAMA

Volumn 310, Issue 15, 2013, Pages 1601-1611

  Pasternak, Björn ^a   Svanström, Henrik ^a   Mølgaard Nielsen, Ditte ^a   Melbye, Mads ^a   Hviid, Anders ^a  

^a STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84885582289     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2013.278343     Document Type: Article

References (26)

1. Lacroix R, Eason E, Melzack R. Nausea and vomiting during pregnancy: a prospective study of its frequency, intensity, and patterns of change. Am J Obstet Gynecol. 2000;182(4):931-937.
2. Niebyl JR. Clinical practice: nausea and vomiting in pregnancy. N Engl J Med. 2010;363(16):1544-1550.
3. Anderka M, Mitchell AA, Louik C, Werler MM, Hernández-Diaz S, Rasmussen SA; National Birth Defects Prevention Study. Medications used to treat nausea and vomiting of pregnancy and the risk of selected birth defects. Birth Defects Res A Clin Mol Teratol. 2012;94(1):22-30.
4. Jarvis S, Nelson-Piercy C. Management of nausea and vomiting in pregnancy. BMJ. 2011;342:d3606.
5. Andrade SE, Gurwitz JH, Davis RL, et al. Prescription drug use in pregnancy. Am J Obstet Gynecol. 2004;191(2):398-407.
6. Matok I, Gorodischer R, Koren G, Sheiner E, Wiznitzer A, Levy A. The safety of metoclopramide use in the first trimester of pregnancy. N Engl J Med. 2009;360(24):2528-2535.
7. Berkovitch M, Elbirt D, Addis A, Schuler-Faccini L, Ornoy A. Fetal effects of metoclopramide therapy for nausea and vomiting of pregnancy. N Engl J Med. 2000;343(6):445-446.
8. Berkovitch M, Mazzota P, Greenberg R, et al. Metoclopramide for nausea and vomiting of pregnancy: a prospective multicenter international study. Am J Perinatol. 2002;19(6):311-316.
9. Sørensen HT, Nielsen GL, Christensen K, Tage-Jensen U, Ekbom A, Baron J; Euromap Study Group. Birth outcome following maternal use of metoclopramide. Br J Clin Pharmacol. 2000;49(3):264-268.
10. Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation. 8th ed. Philadelphia, PA: Lippincott Williams &Wilkins; 2008:1197-1201.
11. Mitchell AA. Studies of drug-induced birth defects. In: Strom BL, ed. Pharmacoepidemiology. 4th ed. West Sussex, England: John Wiley & Sons Ltd; 2005:501-514.
12. Knudsen LB, Olsen J. The Danish Medical Birth Registry. Dan Med Bull. 1998;45(3):320-323.
13. Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health. 2011;39(7)(suppl):30-33.
14. Kildemoes HW, Sørensen HT, Hallas J. The Danish National Prescription Registry. Scand J Public Health. 2011;39(7)(suppl):38-41.
15. Pedersen CB, Gøtzsche H, Møller JO, Mortensen PB. The Danish Civil Registration System: a cohort of eight million persons. Dan Med Bull. 2006;53(4):441-449.
16. Chapter 3.3: Coding of Eurocat Subgroups of Congenital Anomalies (version 2012). In: Eurocat Guide 1.3 and Reference Documents: Instructions for the Registration and Surveillance of Congenital Anomalies. EUROCAT website. http://www.eurocatnetwork.eu/content/EUROCAT-Guide-1.3.pdf. Accessed February 10, 2013.
17. Larsen H, Nielsen GL, Bendsen J, Flint C, Olsen J, Sørensen HT. Predictive value and completeness of the registration of congenital abnormalities in three Danish population-based registries. Scand J Public Health. 2003;31(1):12-16.
18. Agergaard P, Hebert A, Bjerre J, Sørensen KM, Olesen C, Ostergaard JR. Children diagnosed with congenital cardiac malformations at the national university departments of pediatric cardiology: positive predictive values of data in the Danish National Patient Registry. Clin Epidemiol. 2011;3:61-66.
19. Lohse SR, Farkas DK, Lohse N, et al. Validation of spontaneous abortion diagnoses in the Danish National Registry of Patients. Clin Epidemiol. 2010;2:247-250.
20. Harrell FE. Regression Modeling Strategies: With Application to Linear Models, Logistic Regression, and Survival Analysis. 2nd ed. New York, NY: Springer-Verlag New York Inc; 2001:41-51.
21. Austin PC. Some methods of propensity-score matching had superior performance to others: results of an empirical investigation and Monte Carlo simulations. Biom J. 2009;51(1):171-184.
22. Rassen JA, Shelat AA, Myers J, Glynn RJ, Rothman KJ, Schneeweiss S. One-to-many propensity score matching in cohort studies. Pharmacoepidemiol Drug Saf. 2012;21(suppl 2):69-80.
23. Buhimschi CS, Weiner CP. Medications in pregnancy and lactation, part 1: teratology. Obstet Gynecol. 2009;113(1):166-188.
24. Chan RL, Olshan AF, Savitz DA, et al. Severity and duration of nausea and vomiting symptoms in pregnancy and spontaneous abortion. Hum Reprod. 2010;25(11):2907-2912.
25. Weigel RM, Weigel MM. Nausea and vomiting of early pregnancy and pregnancy outcome: a meta-analytical review. Br J Obstet Gynaecol. 1989;96(11):1312-1318.
26. EUROCAT Prevalence Tables, Denmark. EUROCAT website. http://www.eurocat- network.eu/accessprevalencedata/prevalencetables. Acccessed June 19, 2013.